These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 15342288
1. Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I. Superko HR, McGovern ME, Raul E, Garrett B. Am J Cardiol; 2004 Sep 01; 94(5):588-94. PubMed ID: 15342288 [Abstract] [Full Text] [Related]
3. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia. Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD. Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694 [Abstract] [Full Text] [Related]
9. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Griffin BA, Minihane AM, Furlonger N, Chapman C, Murphy M, Williams D, Wright JJ, Williams CM. Clin Sci (Lond); 1999 Sep 01; 97(3):269-76. PubMed ID: 10464051 [Abstract] [Full Text] [Related]
12. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis. Insull W, McGovern ME, Schrott H, Thompson P, Crouse JR, Zieve F, Corbelli J. Arch Intern Med; 2004 May 24; 164(10):1121-7. PubMed ID: 15159270 [Abstract] [Full Text] [Related]
13. Efficacy and tolerability of a new extended-release formulation of nicotinic acid in Korean adults with mixed dyslipidemia: an 8-week, multicenter, prospective, randomized, double-blind, and placebo-controlled trial. Kim SH, Kim MK, Lee HY, Kang HJ, Kim YJ, Park BJ, Kim HS. Clin Ther; 2011 Oct 24; 33(10):1357-64. PubMed ID: 21955937 [Abstract] [Full Text] [Related]
14. Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g). Alrasadi K, Awan Z, Alwaili K, Ruel I, Hafiane A, Krimbou L, Genest J. Am J Cardiol; 2008 Nov 15; 102(10):1341-7. PubMed ID: 18993152 [Abstract] [Full Text] [Related]
15. New perspectives on the use of niacin in the treatment of lipid disorders. McKenney J. Arch Intern Med; 2004 Apr 12; 164(7):697-705. PubMed ID: 15078639 [Abstract] [Full Text] [Related]
16. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype. Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW. Arterioscler Thromb Vasc Biol; 2004 Apr 12; 24(4):744-9. PubMed ID: 14751815 [Abstract] [Full Text] [Related]